drugset / Trial / NCT07681674
Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product
Non-randomizedSingle-groupOpen-labelTreatment
Summary
BiCAP-201 trial offers continued access to Bicycle investigational product treatments zelenectide pevedotin, nuzefatide pevedotin, and BT7480 for participants currently receiving and deriving clinical benefit from one of these treatments in a Bicycle Therapeutics-sponsored clinical trial. Bicycle Therapeutics will continue to monitor longer term safety of these treatments.
Timeline
- Start
- 2026-08-01
- Primary completion
- 2030-05-30
- Completion
- 2030-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BT5528 | Other / unclassified | — | — |
| Subject | BT7480 | Peptide | — | — |
| Subject | Zelenectide pevedotin | Protein / enzyme biologic | — | — |